Insider Purchases: Inside the Buy
Tag: dividend stocks
Rockwell Automation ($ROK): CEO Blake Moret Buys $1.55M in Shares as Q4 Operating Profit Surges 16% 🏭🤖
🏭🤖 Rockwell Automation ($ROK) CEO Blake Moret just bought approximately $1.55 million in shares as Q4 enterprise operating profit jumped 16%. With $1.70 billion in annual free cash flow, strong institutional ownership and growing AI-enabled factory opportunities, the industrial giant has plenty going for it. But at nearly 26× forward earnings, is the stock already priced for success? FunStock Index™: 7.75/10.
Upbound Group ($UPBD): $1.69M Insider Buying Spree, Surging Cash Flow & a 6.3% Dividend 🛋️⚡
🛋️⚡ Seven Upbound Group insiders, including its CEO and CFO, purchased approximately $1.69 million in UPBD shares as quarterly free cash flow more than doubled. With a 6.3% dividend, forward P/E near 4.6× and short interest above 16%, is this overlooked lease-to-own and fintech company a compelling contrarian opportunity—or a value trap? Our FunStock Index™: 8.45/10.
🥤 PepsiCo Stock (PEP): A 4.5% Dividend King Ready for a Turnaround?
PepsiCo combines a roughly 4.5% dividend yield, lower valuation multiples and recovering cash flow with an activist-backed improvement plan. Can product innovation and stronger execution revive growth? Our FunStock Index: 7.75/10—with an important insider footnote.
Banco Bradesco ($BBD): Brazil’s Seismic Market Reset Meets a Banking Turnaround 🇧🇷⚡
Banco Bradesco just surged 18.8%—and the story goes well beyond politics. We revisit BBD after first turning bullish at $3.45, examining 10 straight quarters of improving profits, its R$10B capital raise, insider alignment, income potential and the seismic repricing of Brazilian banks and fintech.
🚢 Star Bulk Carriers (SBLK): $6.9M Insider Buying, 7.2x Forward P/E & a $0.90 Dividend
Eight Star Bulk insiders acquired roughly $6.9 million of SBLK at $28.27 as Q2 net income reached $144.9 million and the board declared a $0.90 dividend. At just 7.2x forward earnings, is this dry-bulk giant genuinely cheap—or simply enjoying the favorable side of a notoriously brutal shipping cycle?
🛡️ Aon (AON): The Chairman Just Bought $6.5M. We’re Still Waiting.
Aon Chairman Lester Knight just bought roughly $6.5 million of AON stock after the company announced its massive $17 billion USI acquisition. The insider signal is compelling—but with leverage headed toward 4.8×, buybacks paused and integration risk rising, is AON finally cheap enough?
👟 DICK’S Sporting Goods (DKS): Insiders Buy $2.9M After a 30% Crash
DICK’S Sporting Goods plunged roughly 30% as Foot Locker weakness rattled Wall Street. Then three directors bought $2.94 million. With core DICK’S comps up 4.9%, operating cash flow at $792 million and the stock at 9.3x forward earnings, is Wall Street pricing temporary integration pain like permanent deterioration?
🐾 Zoetis (ZTS): A Premium Veterinary Titan Sitting in the Doghouse
Zoetis (ZTS) may be one of the most interesting “quality in the doghouse” setups of 2026. The global animal-health leader is still profitable, institutionally loved, and backed by powerful pet-humanization trends — yet soft U.S. pet spending, competition, and lowered guidance have crushed the stock. With directors buying near the lows and forward P/E near 11x, is ZTS finally becoming a value play?
🚰 Primo Brands (PRMB): CEO Buys $2M Dip as an $800M Free Cash Flow Giant Emerges 💧⚡
Primo Brands isn't simply selling bottled water.
It's quietly building one of North America's largest hydration infrastructure platforms.
With repeat CEO insider buying, nearly $800 million in annual free cash flow, raised guidance, and exceptional institutional ownership, PRMB deserves a closer look.
💊 Pfizer (PFE): Why a Former Vanguard CEO Just Bought Nearly $1 Million of This 6.4% Dividend Stock
Pfizer has spent years under pressure following the collapse of pandemic-era revenues. Yet beneath the headlines, the company's non-COVID business is strengthening, oncology is expanding through Seagen, and two highly respected directors—including former Vanguard CEO and CIO Tim Buckley—recently invested nearly $2 million of their own money. We examine whether Wall Street is overlooking one of healthcare's most compelling value opportunities.
Quick links
Search
About/Leadership
Editorial Process
Privacy Policy
Refund Policy
Shipping Policy
Terms of Service
Contact us
About us
FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.
